The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Targeting B-cell malignancies: Impact of an educational curriculum on BTK inhibitors.
 
Lauren Willis
No Relationships to Disclose
 
Mindy Tanzola
No Relationships to Disclose
 
Richard Caracio
No Relationships to Disclose
 
Katie S. Lucero
No Relationships to Disclose
 
Bijal D. Shah
Honoraria - Pharmacyclics/Janssen
Consulting or Advisory Role - Adaptive Biotechnologies
Research Funding - Incyte; Jazz Pharmaceuticals (Inst)
 
Jennifer Ann Woyach
Consulting or Advisory Role - Janssen; Pharmacyclics
Research Funding - Abbvie; Janssen; Karyopharm Therapeutics; Loxo; MorphoSys; Pharmacyclics
 
Richard R. Furman
Honoraria - Genentech/Roche; Janssen; Pharmacyclics
Consulting or Advisory Role - Abbvie; Acerta Pharma; AstraZeneca; Genentech/Roche; Gilead Sciences; Janssen Biotech; Loxo; Pharmacyclics; Sunesis Pharmaceuticals; TG Therapeutics; Verastem
Research Funding - Acerta Pharma; TG Therapeutics
Expert Testimony - Abbvie
Other Relationship - Abbvie; Incyte; Janssen Biotech
 
Michael Wang
Stock and Other Ownership Interests - More Health
Honoraria - Dava Oncology; Janssen Research & Development; OM Pharmaceutical Industries; Peerview
Consulting or Advisory Role - AstraZeneca; AxImmune; Bioinvent; Celgene; iOMEDICO; Janssen Research & Development; Juno Therapeutics; More Health; Pharmacyclics/Janssen; Pulse Biosciences
Research Funding - Acerta Pharma; Amgen; AstraZeneca; BeiGene; Bioinvent; Janssen Research & Development; Juno Therapeutics; Karus Therapeutics; Kite, a Gilead company; Novartis; Oncternal Therapeutics; Pharmacyclics
Travel, Accommodations, Expenses - AstraZeneca; Celgene; Dava Oncology; Janssen Research & Development; OM Pharmaceutical Industries
 
Jennifer R. Brown
Honoraria - Abbvie; Janssen Oncology
Consulting or Advisory Role - Abbvie; Astellas Pharma; AstraZeneca; Celgene; Gilead Sciences; Infinity Pharmaceuticals; Janssen; Pharmacyclics; Redx Pharma; Roche/Genentech; Sun Pharma
Research Funding - Gilead Sciences